# Descemet's membrane endothelial keratoplasty with scraping without descemetorhexis (DMEK-SWD) in a failed penetrating keratoplasty

**Authors:** Alexander Wallace, Mohit Parekh, Sabrina Vaccaro, Francesco Semeraro, Vito Romano

PMC · DOI: 10.1016/j.ajoc.2025.102499 · American Journal of Ophthalmology Case Reports · 2025-12-09

## TL;DR

A new surgical technique called DMEK-SWD is introduced to treat failed corneal transplants, showing promising visual and corneal thickness improvements in two patients.

## Contribution

The novel DMEK-SWD technique is introduced for treating failed penetrating keratoplasty without descemetorhexis.

## Key findings

- DMEK-SWD showed improved visual acuity and reduced corneal thickness in two patients with failed transplants.
- Graft endothelial cell density remained stable post-surgery in both cases.
- The technique demonstrated a mean graft clearance time of 1.5 weeks.

## Abstract

To introduce a novel treatment for a secondary failed penetrating keratoplasty (PK), termed Descemet's Membrane Endothelial Keratoplasty with endothelial scraping and without descemetorhexis (DMEK-SWD), through the presentation of two clinical cases.

In this prospective, single-center case series, two patients with previous PK for keratoconus developed endothelial decompensation, presenting with decreased visual acuity (Patient A: counting fingers; Patient B: 0.8 logMAR) and increased central corneal thickness (A: 735 μm; B: 653 μm). DMEK-SWD was performed using a 7.5-mm cell scraper through the temporal port to mechanically remove the host endothelium. A pre-stripped 7.5-mm DMEK graft was inserted using a standardized no-touch technique. Postoperative management included subconjunctival injections of gentamycin and dexamethasone. Graft attachment was maintained in both cases, although Patient B required single rebubbling procedure.

Postoperative graft endothelial cell density (ECD), measured from confocal imaging (HRT3-RCM Cell Count), was 1,125 cells/mm2 at 12 months in Patient A and 1,544 cells/mm2 at 8 months in Patient B. At final follow-up (A: 18 months; B: 8 months), both patients showed improved best-corrected visual acuity (A: 0.2 logMAR; B: 0 logMAR) and reduced CCT (A: 496 μm; B: 505 μm).

This pilot study demonstrates the feasibility of DMEK-SWD in treating failed PK, with a mean graft clearance time of 1.5 weeks for the two cases analyzed. The technique may represent a promising alternative to repeat full-thickness transplantation and supports further investigation in larger cohorts. Given the very small sample size and the incomplete availability of endothelial cell count data, these findings should be regarded as preliminary.

## Linked entities

- **Diseases:** keratoconus (MONDO:0015486)

## Full-text entities

- **Diseases:** keratoconus (MESH:D007640)
- **Chemicals:** dexamethasone (MESH:D003907), gentamycin (MESH:D005839), DMEK (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12756570/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12756570/full.md

## References

21 references — full list in the complete paper: https://tomesphere.com/paper/PMC12756570/full.md

---
Source: https://tomesphere.com/paper/PMC12756570